 get the drugs on their behalf, are buying from those reliable manufacturers. It doesn't have to be for every single contract, but just enough to make a big shift in the market. That is going to cost a little bit more, and that Senate finance bill, the bipartisan one that we were just hearing about, includes a provision for bumping up essentially the payments to